| Financial Year |
March 31 2023 |
| Monetary Funds |
563,493,214.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,500.00 |
| Accounts Receivable |
147,486,939.02 |
| Advances to Suppliers |
5,163,196.58 |
| Other Receivables |
823,153.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
206,249.99 |
| Dividend Receivable |
-- |
| Inventories |
214,323,997.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,690,440.79 |
| Total Current Assets |
932,989,441.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
71,778,365.71 |
| Investment Properties |
47,710,241.43 |
| Fixed Assetes |
276,271,269.65 |
| Under-construction Projects |
2,160,887.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,553,840.47 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
150,737.06 |
| Deferred Income Tax Assets |
674,190.47 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
421,299,532.19 |
| Total Assets |
1,354,288,973.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
221,896,451.36 |
| Accounts Payable |
80,030,753.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,590,102.68 |
| Taxes Payable |
11,820,133.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,876,657.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
344,481,300.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,756,373.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,756,373.16 |
| Total Liabilities |
349,237,673.90 |
| Paid-In Capital(Or Share Stock) |
294,302,115.00 |
| Capital Surplus |
1,170,425,647.23 |
| Surplus Reserve |
41,669,437.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-421,737,743.47 |
| Minority Stockholder's Interest |
-79,608,156.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,084,659,456.38 |
| Owner's Equity（Stockholder's Equity） |
1,005,051,299.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,354,288,973.48 |
